Novartis' heart-failure drug fails in clinical trial; Sanofi, Regeneron file Dupixent patent suit; FDA approves Newron's Xadago for PD
Per the credit ratings agency, more uninsured Americans will lead to less demand for healthcare services and treatments.
As we build health solutions, making decisions in office parks and around conference tables, it's easy to lose the individual person through the scale of our work.
In short, he'll be further along the learning curve than anyone ever tapped for the nation's number-one public health regulatory slot.
The FDA considers creating Office of Patient Affairs; Alexion to cut 7% of workforce; FDA committee votes against painkiller's benefits
He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.
About 30% of patients are more likely to fill a prescription after being exposed to healthcare ads at the point of care, according to Kantar Media.
Pfizer receives subpoena over patient assistance programs; drugmakers raise prices less this January than last; lawmakers have new plan to repeal ACA
Few questions give healthcare marketers more heart palpitations than this one: "How do you know it will work?"
Teva Pharmaceutical Industries' Copaxone is by far the top-selling drug, bringing in $3.2 billion in U.S. sales in 2015.
The 2009 documentary offers a wealth of detail. Which is why it makes no sense that Genentech doesn't want you to see the damn thing.
Each of the approaches is valid and more ambitious than a great majority of the campaigns that preceded them.
Diabetes patients sue drugmakers over price increases; the FTC opens Mylan investigation; Fitbit to ramp up marketing
Here are six creative campaigns that use creativity to connect with the audience.
Despite their blockbuster status and distinction as the world's most widely prescribed class of drugs, statins may not be the best option for all patients with elevated low density lipoprotein (LDL) cholesterol levels.
Gilead forms network to encourage access to hep.-C drugs; Dentsu CEO to resign following the suicide of a staffer; BI to divest animal-health products
Allergan's board endorses its social contract with patients; drugmakers that market painkillers are hiring DEA officials; the FDA approves new Biogen drug
More barriers separate doctors and patients than ever before, from rising costs and time constraints to electronic health records and smartphones.
Given its modern-day ubiquity, it's easy to forget that pharma DTC didn't exist until the 1980s rolled around.
Sharecare acquires virtual-reality developer; Novo Nordisk to cut 1,000 jobs; the FDA approves Medtronic's automated insulin pump
Really? Is this the new healthcare math — the fewer the insurance companies, the greater the competition and the lower the premiums?
Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced AnalyticsSeptember 21, 2016
During this seminar, attendees will learn how advanced data analytics can be applied to gain a measurable competitive advantage.
In this webcast, TrialCard VP of analytic services Paul LeVine and senior analytic consultant Robert Leedom underscore how affordability programs provide the ideal venue for focusing on adherence issues.
In this sponsored podcast, MM&M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.
The latest TV campaign from Mars features a woman with cerebral palsy joking about her love life.
The availability of online medical information is changing the way doctors share and receive information — both among themselves and with their patients.
Will this payer pressure pose an existential threat to co-pay cards even though patients love them?
Many patients find it difficult to ask questions of their physician.
It's unlikely that pharma will ever achieve the degree of consumer love directed at Amazon and Apple but the shift taking place will open up doors for pharma organizations.
The power of hackathons is now magnified because of the power of the internet and social media, giving both patients and healthcare professionals a global platform for their voices.
- Five things for pharma marketers to know: Wednesday, March 22, 2017
- Five things for pharma marketers to know: Monday, March 20, 2017
- Novartis aims to bring first oral asthma drug to market in two decades
- Drugmakers target severe asthma patients with biologics, but payers raise pricing issue
- What five different pharma marketing careers look like
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Digital IDs become focus as drugmakers seek to track doctors' behavior online
- Some CME experts remain skeptical when it comes to social media
- Five things for pharma marketers to know: Monday, March 27, 2017
- P&G exec who led Always #LikeAGirl campaign moves to comms leadership role at Novartis
- Pro ad report: All the data on journal spending in 2016
- SPONSORED: Video Interview with Tim Armand, Health Union
- Five things for pharma marketers to know: Friday, March 24, 2017